Completed PHASE3 INTERVENTIONAL 2-arm NCT02466022

Dexmedetomidine for Sedation in Total Knee Replacements

Does Single Dose Dexmedetomidine for Procedural Sedation Reduce Post-operative Pain in Total Knee Arthroplasty? A Randomized Control Study

Sponsor: University of Saskatchewan

Conditions Post-operative Pain for Total Knee Arthroplasty

Interventions Bupivicaine Dexmedetomidine Fentanyl Midazolam Normal Saline

Updated 6 times since 2017 Last updated: Jun 14, 2016 Started: Jun 30, 2015 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Post-operative Pain for Total Knee Arthroplasty, this trial is completed. The trial is conducted by University of Saskatchewan and has accumulated 6 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Saskatchewan

Data source: University of Saskatchewan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Regina, Canada